Obtenga las últimas noticias sobre las acciones de Plus Therapeutics con actualizaciones sobre las tendencias del mercado, las finanzas y el análisis de Benzinga. Manténgase informado sobre el rendimiento de PSTV

Últimas noticias sobre

PLUS THERAPEUTICS INC

Plus Therapeutics

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

Shanghai,,China,-,June,29,,2023:,Saic,Roewe,Feifan,F7

Tech

BPMC

CRDO

PSTV

SAIC

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este lunes: CPB, SAIC, PSTV, BPMC y CRDO.

5 acciones en el foco este lunes: CPB, SAIC, PSTV, BPMC y CRDO

Movimiento de acciones

News

Intraday Update

Markets

Movers

Trading Ideas

ALUR

AUID

BHAT

BNTC

GCTK

INNV

MCVT

OUST

PNBK

RVSB

TNMG

USAR

XHLD

Ouster sorprende con resultados mejores de lo esperado y sus acciones suben un 8,95%. Descubre las acciones que dominan el premercado.

Las acciones de Ouster (OUST) suben un 9%; Aquí están 20 acciones que se mueven en el premercado de EE.UU.

Plus Therapeutics Inc

POSTAL SVGS CHINA UNS/ADR by Postal Svgs Bk of China Ltd.

Postal Savings Bank Of China Co Ltd

Health Care

Press Releases

Plus Therapeutics Announces FDA Agreement to Initiate ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases

Plus Therapeutics Announces Initial Patients Successfully Treated in ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases

Plus Therapeutics Announces Two CNSide Presentations at the Upcoming SNO/ASCO CNS Metastases Conference

Plus Therapeutics Presents ReSPECT-LM Clinical Trial Results for REYOBIQ™ in Patients with Leptomeningeal Metastases

Contracts

Plus Therapeutics Announces $1.6 Million Advance Payment from CPRIT

Plus Therapeutics Provides US Launch Update for its CNSide® Diagnostic

Plus Therapeutics Presents Positive CNSide CSF Assay Platform Results at the 2025 SNO/ASCO CNS Metastases Conference

Earnings

Plus Therapeutics Reports Second Quarter Financial Results and Recent Business Highlights

Plus Therapeutics Reports Stockholders' Equity in Excess of $2.5 million in Compliance with Nasdaq Equity Requirements

Plus Therapeutics Presents Positive ReSPECT-LM Clinical Trial Results of REYOBIQ™ in Leptomeningeal Metastases

Acrivon Therapeutics, Inc. - Common Stock

Acrivon Therapeutics

ALX Oncology Holdings Inc. - Common Stock

ALX Oncology Holdings

Annovis Bio

Actinium Pharmaceuticals, Inc. (Delaware) Common Stock

Actinium Pharma

Barinthus Biotherapeutics plc - American Depositary Shares

Barinthus Biotherapeutics

Clene

Precision BioSciences, Inc. - Common Stock

Precision BioSciences

Equillium

FibroGen

Generation Bio

ImmuCell

Century Therapeutics, Inc. - Common Stock

Century Therapeutics

Jasper Therapeutics, Inc. - Class A Common Stock

Jasper Therapeutics

Kalaris Therapeutics, Inc. - Common Stock

Kalaris Therapeutics

Karyopharm Therapeutics Inc. - Common Stock

Karyopharm Therapeutics

Lantern Pharma

MAIA Biotechnology

Medicus Pharma

PDS Biotechnology Corporation - Common Stock

PDS Biotechnology

Propanc Biopharma

Radiopharm Theranostics Limited - American Depositary Shares

Radiopharm Theranostics

Renovaro

Senti Biosciences

Shattuck Labs

Tempest Therapeutics, Inc. - Common Stock

Tempest Therapeutics

Maxim Group

HC Wainwright & Co.

D. Boral Capital

Ascendiant Capital

JonesTrading

Screenshot 2024-03-29 at 1.10.09 AM

Biotech

General

This Biotech Is Creating Targeted Radiotherapuetics For Some Of The Deadliest Cancers

Comments

Plus Therapeutics Noticias bursátiles

Noticias

Últimas noticias sobre

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL